ABSTRACT

As researchers, clinicians, and policymakers continue to struggle with balancing civil liberties and community safety, this past decade has wit­ nessed a virtual explosion in the development of second-and third-gen­ eration risk assessment instruments (Monahan, 1992). Central to this work on risk appraisals has been the introduction, for clinical purposes, of the Psychopathy Checklist-Revised (PCL-R) to applied settings. For a number of reasons, the PCL-R appears to have captured the interests of clinicians, and the diagnosis is increasingly being employed in risk assess­ ment strategies of prisoners and forensic patients at various stages with­ in the criminal justice process — from pretrial assessments to postrelease risk management (see chap. 3). Although the PCL-R is a measure of crim­ inal psychopathy, for reasons to be discussed shortly, it has become increasingly popular within the risk assessment paradigm.